Home
About Us
News
R&D
Manufacture
Products
Culture

Qingfeng Pharmaceutical Group

中文
English
Providing sustainable and high-quality service for human health
Become a leading provider of medical health products and service
Innovating, Efficiency, Striving, Sharing
魔方导航
About Us

News

R&D

Manufactur...

Products

Culture

News
‍
Qingfeng will attend the 2025 J.P. Morgan Healthcare Conference
Qingfeng Pharmaceutical's Eribulin Mesilate Injection Approved for Marketing in the U.S.
Company News
2024/07/08
First in China! Qingfeng Pharmaceutical's Brivaracetam Tablets Approved for Marketing
Company News
2024/07/06
R&D
Innovation Platform
Innovation Platform
R&D Results
R&D Results
R&D Talents
R&D Talents
Research Cooperation
Research Cooperation
Home Page
Member Center
PC version
English
中文
English


©2020-2022 Qingfeng Group All rights reserved


PC version  
赣ICP备2022007616号-1 赣公网安备 36070202000018号